A manufacturing facility shall have every process lot of a medical cannabinoid product, to be packaged in a container for transfer to a dispensary, tested for the following:

1. Pesticides and degradation compounds in accordance with section 33-44-01-47.

2. Microbiological contaminants and mycotoxins in accordance with section 33-44-01-48.

3. Heavy metals in accordance with section 33-44-01-48.1.

4. Solvents in accordance with section 33-44-01-49.

5. Concentration in accordance with section 33-44-01-51.

History: Effective April 1, 2018; amended effective October 1, 2019.